Drugs for treatment of very high blood pressure during pregnancy

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Duley, Lelia ^a   Meher, Shireen ^b   Jones, Leanne ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; DIAZOXIDE; HYDRALAZINE; KETANSERIN; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; NIMODIPINE; NITRIC ACID DERIVATIVE; PRAZOSIN; PROSTACYCLIN; URAPIDIL; ANTIHYPERTENSIVE AGENT;

APGAR SCORE; BRAIN HEMORRHAGE; BREAST FEEDING; CEREBROVASCULAR ACCIDENT; CESAREAN SECTION; CHILD DEVELOPMENT; CHILD GROWTH; COMPARATIVE STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DRUG EFFECT; DRUG RESPONSE; DYSPNEA; ECLAMPSIA; EPIGASTRIC PAIN; HEADACHE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HEART PALPITATION; HELLP SYNDROME; HOT FLUSH; HUMAN; HYPOTENSION; KIDNEY FAILURE; LIVER FAILURE; LUNG EDEMA; MATERNAL ATTITUDE; MATERNAL DEATH; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; NAUSEA; NECROTIZING ENTERITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INFECTION; NEWBORN MORTALITY; OUTCOME ASSESSMENT; POSTNATAL DEPRESSION; POSTPARTUM HEMORRHAGE; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; RETROLENTAL FIBROPLASIA; RETROSTERNAL PAIN; REVIEW; SCALP PRURITUS; SIDE EFFECT; SOLUTIO PLACENTAE; SOMNOLENCE; STILLBIRTH; SYSTEMATIC REVIEW; THORAX PAIN; TINNITUS; VISUAL DISORDER; VOMITING; FEMALE; META ANALYSIS; PREECLAMPSIA; PREGNANCY; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA;

ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891648183     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001449.pub3     Document Type: Review

References (176)

1. Voto LS, Quiroga CA, Lapidus AM, Catuzzi P, Uranga IF, Margulies M. Effectiveness of antihypertensive drugs in the treatment of hypertension in pregnancy. Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy 1990;9(3):339-48.
2. Michael CA. Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 1986;26:26-9.
3. Hennessy A, Thornton C, Makris A, Ogle R, Henderson-Smart D, Gillin A, et al. Parenteral intravenous optimal therapy trial - A RCT of hydralazine versus mini-bolus diazoxide for hypertensive crises in the obstetric setting [abstract]. Hypertension in Pregnancy 2006;25(Suppl 1):22.
4. Hennessy A, Thornton CE, Makris A, Ogle RF, Henderson-Smart DJ, Gillin AG, et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the pivot trial. Australian and New Zealand Journal of Obstetrics and Gynaecology 2007;47(4):279-85.
5. Hennessy AM. Diazoxide versus hydralazine for acute treatment of very high blood pressure in pregnancy. Personal communication.
6. Martins-Costa S, Ramos JG, Barros E, Bruno RM, Costa CA. Randomized, controlled trial of hydralazine versus nifedpine in preeclamptic women with acute hypertension. Clinical and Experimental Hypertension 1992;B11(1):25-44.
7. Mesquita MR, Attalah AN, Camano L, Bertini AM. The use of hydralazine and nifedipine as treatment of hypertension emergency during pregnancy. Proceedings of 2nd World Congress of Perinatal Medicine; 1993 September 19-24; Rome, Italy. 1993:41.
8. de Souza MR, Nagib A, Bertini AM. Use of hydralazine and nifedipine in hypertensive emergency in pregnancy [Empleo de la hidralazina y de la nifedipina en las emergencias hipertensivas en la gestacion]. Progresos de Obstetricia y Ginecologia 1994;37:90-6.
9. de Souza Mesquita MR, Atallah AN, Bertini AM. The use of hydralazine and nifedipine as treatment for hypertension emergency during pregnancy. Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland. 1994:163.
10. Baggio MR, Martins WP, Calderon AC, Berezowski AT, Marcolin AC, Duarte G, et al. Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial. Ultrasound in Medicine & Biology 2011;37(1):53-8.
11. Moore MP, Redman CWG. The treatment of hypertension in pregnancy. Current Medical Research and Opinion 1982;8:S39-S46.
12. Vizitiu R, Krauss-Grignard M, Garcia V, Valentin L, Samain E, Diemunsch P. Urapidyl for hypertension control in severe pre-eclampsia: a comparative study with nicardipine. Critical Care 2010;14 Suppl 1:S48.
13. Schulz M, Wacker J, Bastert G. Effect of urapidil in antihypertensive therapy of preeclampsia on newborns. Zentralblatt fur Gynakologie 2001;123(9):529-33.
14. Wacker J, Christ M, Grischke EM, Bastert G. Treatment of patients with pre-eclampsia with urapidil. International Journal of Gynecology & Obstetrics 1994;46:121.
15. Wacker J, Christ M, Muller J, Grischke EM, Bastert G. Treatment of patients with pre-eclampsia with urapidil. Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland. 1994:186.
16. Wacker J, Piel P, Bastert G. The treatment of pre-eclampsia with urapidil. Proceedings of 10th World Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA. 1996:185.
17. Wacker J, Schulz M, Werner P, Bastert G. Fetal outcome after treatment of hypertension in patients with preeclampsia with urapidil [abstract]. 12th World Congress of the International Society for the Study of Hypertension in Pregnancy; 2000 July 9-15; Paris, France. 2000:1.
18. Wacker J, Werner P, Walter-Sack I, Bastert G. Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil. Nephrology, Dialysis, Transplantation 1998;13:318-25.
19. Wacker JR, Wagner BK, Briese V, Schauf B, Heilmann L, Bartz C, et al. Antihypertensive therapy in patients with pre-eclampsia: a prospective randomised multicentre study comparing dihydralazine with urapidil. European Journal of Obstetrics & Gynecology and Reproductive Biology 2006;127(2):160-5.
20. Aswathkumar R, Gilvaz S. Management of severe hypertension in pregnancy: prospective comparison of labetalol vs nifedipine [abstract]. 49th All India Congress of Obstetrics and Gynaecology; 2006 Jan 6-9; Cochin, Kerala State, India. 2006:38.
21. Desai BB, Swamy MK, Patil KP. A randomized controlled trial of oral nifedipine vs intravenous labetalol in acute control of blood pressure in hypertensive emergencies of pregnancy. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India. 2011:179.
22. Aali B, Nejad SS. Nifedipine or hydralazine as a first-line agent to control hypertension in severe pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica 2002;81:25-30.
23. Rezaei Z, Sharbaf FR, Pourmojieb M, Youefzadeh-Fard Y, Motevalian M, Khazaeipour Z, et al. Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy. Acta Medica Iranica 2011;49(11):701-6.
24. Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG: an international journal of obstetrics and gynaecology 2012;119(1):78-85.
25. Rodriguez RJW, Amaya LAH. Severe preeclamsia. Nifedipine versus chlorpromazine in the management of the acute hypertensive state [Pre-eclampsia severa. Nifedipina versus Clorpromazina en el manejo del estado hipertensivo agudo]. Revista Medica Instituto Mexicano del Seguro Social 1989;27:359-63.
26. Walss Rodriguez RJ, Flores Padilla LM. Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive drugs. Ginecologia y Obstetricia de Mexico 1993;61:76-9.
27. Vargas AG, Salmeron PI, Sanchez GAR, Limenez AAL, Rubio GAF. Efficacy of isosorbide in aerosol form in the management of hypertensive crisis in severe preeclampsia. Ginecologia y Obstetricia de Mexico 1998;66:316-9.
28. Bolte AC, Dekker GA, van Eyck J, Bruinse HW, Kanhai HH, de Vries A. Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early onset pre-eclampsia. American Journal of Obstetrics and Gynecology 1995;172(1 Pt 2):384.
29. Bolte AC, Dekker GA, van Eyck J, Bruinse HW, Kanhai HH, de Vries A. Ketanserin versus dihydralazine in the treatment of early onset pre-eclampsia. Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA. 1996:148.
30. Bolte AC, Dekker GA, van Eyck J, Bruinse HW, Kanhai HH, de Vries A, et al. Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early onset preeclampsia. Proceedings of the International Society for the Study of Hypertension in Pregnancy, European Branch; 1995 July 20-22; Leuven Belgium. 1995:18.
31. Bolte AC, Dekker GA, van Eyck J, Strack van Schijndel RJM, de Vries A, van Geijn HP. Comparison of the effectivity and safety of ketanserin vs dihydralazine in the treatment of severe pre-eclampsia. Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia. 1994:42.
32. Bolte AC, van Eyck J, Kanhai H, Bruinse HW, van Geijn HP, Dekker GA. Ketanserin versus dihydralazine in the management of severe early onset preeclampsia: maternal outcome. American Journal of Obstetrics and Gynecology 1999;180:371-7.
33. Bolte AC, van Eyck J, Strack van Schijndel RJ, van Geijn HP, Dekker GA. The haemodynamic effects of ketanserin versus dihydralazine in severe early onset hypertension in pregnancy. British Journal of Obstetrics and Gynaecology 1998;105:723-31.
34. Bolte A, Van Geijn H, Dekker G. Use of ketanserin in hypertensive disorders of pregnancy [abstract]. American Journal of Obstetrics and Gynecology 2001;185(6 Suppl):S171.
35. Bolte AC, van Geijin HP, Bekedam DJ, Dekker GA. Ketanserin, a serotonin2 receptor blocker, for hypertension in pregnancy. Hypertension in Pregnancy 2002;21(Suppl 1):9.
36. Bolte BC, Geijn HPV, Bekedam DJ, Dekker GA. Ketanserin for hypertension in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2003;43:179.
37. Belfort M, Anthony J, Saade G, Nimodipine Study Group. Interim report of the nimodipine vs. magnesium sulfate for seizure prophylaxis in severe preeclampsia study: an international, randomized controlled trial. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S7.
38. Belfort M, Saade G, Yared M, Abedejos P, Dorman K. Change in estimated cerebral perfusion pressure following nimodipine or magnesium sulfate in patients with severe preeclampsia. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S114.
39. Belfort MA, Anthony J, Saade GR, Allen JC, Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. New England Journal of Medicine 2003;348:304-11.
40. Belfort MA, Saade GR, Yared M, Grunewald C, Herd JA, Varner MA, et al. Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia. American Journal of Obstetrics and Gynecology 1999;181:402-7.
41. Hollenberg NK. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. Current Hypertension Reports 2003;5(4):288-9.
42. Harper A, Murnaghan GA. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. British Journal of Obstetrics and Gynaecology 1991;98:453-9.
43. Vigil-De Gracia P, Lasso M, Ruiz E, Vega-Malek JC, de Mena FT, Lopez JC, et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. European Journal of Obstetrics & Gynecology and Reproductive Biology 2006;128:157-62.
44. Ashe RG, Moodley J, Richards AM, Philpott RH. Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. South African Medical Journal 1987;71:354-6.
45. Moodley J. The use of nifedipine in acute hypertensive emergencies of pregnancy. Proceedings of 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Canada. 1988:141.
46. Seabe SJ, Moodley J, Becker P. Nifedipine in acute hypertensive emergencies in pregnancy. South African Medical Journal 1989;76:248-50.
47. Moodley J, Gouws E. A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy. British Journal of Obstetrics and Gynaecology 1992;99:727-30.
48. Rossouw HJ, Howarth G, Odendaal HJ. Ketanserin and hydralazine in hypertension in pregnancy - a randomised double-blind trial. South African Medical Journal 1995;85:525-8.
49. Howarth GR, Seris A, Venter C, Pattinson RC. A randomized controlled pilot study comparing urapidil to dihydralazine in the management of severe hypertension in pregnancy. Hypertension in Pregnancy 1997;16:213-21.
50. Pattinson RC, Seris A, Venter CP, Howarth G. Urapidil versus dihydralazine for control of severe hypertension in pregnancy: a pilot study. Proceedings of the 12th Conference on Priorities in Perinatal Care; 1993; South Africa. 1993:140-3.
51. Maharaj B, Khedun SM, Moodley J, van der Byl K, Rapiti N. A comparative study of intravenous isradipine and dihydralazine in the treatment of severe hypertension of pregnancy in black patients. Hypertension in Pregnancy 1997;16:1-9.
52. Maharaj B, Moodley J, Khedun SM, Rapiti N, van der Byl K. Intravenous isradipine in the management of severe hypertension in pregnancy. Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA. 1996:131.
53. Maharaj B, Moodley J, Khedun SM, Rapiti N, van der Byl K. Intravenous isradipine in the management of severe hypertension in pregnancy. Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia. 1994:158.
54. Steyn DW, Odendaal HJ. Dihydralazine or ketanserin for severe hypertension in pregnancy?. Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia. 1994:152.
55. Steyn DW, Odendaal HJ. Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results. European Journal of Obstetrics & Gynecology and Reproductive Biology 1997;75:155-9.
56. Hall D, Odendaal H, Steyn D, Smith M, Carstens E. Prazosin or nifedipine as a second agent to control early severe hypertension in pregnancy - a randomized controlled trial. 29th Congress of the South African Society of Obstetricians and Gynaecologists; 1998 March 8-12; South Africa. 1998.
57. Hall DR, Odendaal HJ, Steyn DW, Smith M. Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology 2000;107:759-65.
58. Hall DR, Odendaal HJ, Steyn DW, Smith M. Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial. Hypertension in Pregnancy 2000;19(Suppl 1):12.
59. Hall DR, Odendaal HJ, Steyn DW, Smith M. Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial. Women's Health - into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3-6; Cape Town South Africa. RCOG, 1999:49.
60. Saudan P, Billieux MH, Pechere A, Irion O, Savoldelli G, Boulvain M. Which first-line drug to control severe hypertension in pregnancy? A pilot study. Pregnancy Hypertension 2012;2(3):182.
61. Elatrous S, Nouira S, Ouanes Besbes L, Marghli S, Boussarssar M, Sakkouhi M, et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive Care Medicine 2002;28(9):1281-6.
62. Belfort M, Taskin O, Buhur A, Saade G, Yalcinoglu A. Intravenous nimodipine in the management of severe preeclampsia: a double blind randomised controlled clinical trial. Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA. 1996:124.
63. Mabie WC, Gonzalez AR, Amon E, Sibai BM. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986; San Antonio, USA. 1986:221.
64. Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstetrics & Gynecology 1987;70:328-33.
65. Mabie WC, Gonzalez-Ruiz A, Amon E, Sibai BM. A comparative trial of labetolol and hydralazine for acute management of severe hypertension complicating pregnancy. Proceedings of 5th International Congress, International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK. 1987:91.
66. Adair CD, Luper A, Rose JC, Russell G, Veille JC, Buckalew VM. The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial. Journal of Perinatology 2009;29(4):284-9.
67. Adair CD, Buckalew V, Graves SW, Chauhan N, Lam G, DEEP studygroup. Digoxin Immune Fab treatment for severe preeclampsia; relationship between response and baseline endogenous digitalis-like factor. Pregnancy Hypertension 2010;1 Suppl 1:S21.
68. Adair CD, Buckalew VM, Graves SW, Lam GK, Johnson DD, Saade G, et al. Digoxin immune fab treatment for severe preeclampsia. American Journal of Perinatology 2010;27(8):655-62.
69. Anonymous Sildenafil citrate for the treatment of established pre-eclampsia (ongoing trial). ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 21 March 2006).
70. Voto L, Lapidus A, Neira J, Margulies M. Atenolol versus alpha methyl dopa in the treatment of hypertension in pregnancy. Proceedings of the 5th International Congress, International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK, 1986. 1986:138.
71. Aslam A, Talat W. Pregnancy induced hypertension; anti-hypertensive therapy in a study using single drug versus multiple drugs. Professional Medical Journal 2007;14(1):30-2.
72. Brown MA, Buddle ML, Farrell T, Davis GK. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. American Journal of Obstetrics and Gynecology 2002;187:1046-50.
73. Buddle ML, Brown MA, Farrell T. Rapid treatment of severe hypertension in pregnancy. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology; 2001 September 5-7; Darwin, Australia. 2001:118.
74. Begum MR, Quadir E, Begum A, Akhter S, Rahman K. Management of hypertensive emergencies of pregnancy by hydralazine bolus injection vs continuous drip--a comparative study. Medscape Womens Health eJournal 2002;7(5):1-6.
75. Belfort MA. Labetalol versus MgSO4 for the prevention of eclampsia trial (ongoing trial). ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 21 March 2006).
76. Kahhale S, Carrara W, Barros ACSD, Zugaib M, Neme B. A comparative study between treated (beta-blocker pindolol) and untreated chronic hypertension. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands. 1984:56.
77. Kahhale S, Zugaib M, Carrara W, Jota de Paula F, Sabbaga E, Neme B. Comparative study of chronic hypertensive pregnant women treated and non-treated with pindolol. Ginecologia e Obstetricia Brasileiras 1985;8(2):85-9.
78. Bruno RM, Germany L, Behle I, Barros E. Nifedipine versus hydralazine: randomized, placebo-controlled and double blind trial in severe hypertension complicating pregnancy [Nifedipina versus hidralazina: estudo randomizado e duplo cego no tratemento agudo da hipertensao arterial severa na gravidez]. Revista do Hospital de Clinicas de Porto Alegre 1988;8:75-8.
79. Atallah A, Delascio D, Santos J, Mesquita G, Kenj G. Double blinded randomized controlled study using hydralazine or nifedipine for hypertensives crisis in pregnancy. World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil. 1988:181.
80. Atallah AN, de Souza Mesquita MR, dos Santos JFK, Bertini AM, Gebara M, Camano L, et al. A randomized controlled study of hydralazine and nifedipine in hypertensive crisis during pregnancy. Revista Brasileira de Ginecologia y Obstetricia 1990;12:10-4.
81. Yang X, Liu Y. The effect of nifedipine on postpartum blood loss in patients with pregnancy induced hypertension [Chinese]. Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics & Gynecology] 2000;35(3):151-2.
82. Devi R, Anjali T. Intravenous labetalol versus oral nifedipine in the treatment of severe hypertension in pregnancy. Kuwait Medical Journal 2012;44(4):287-90.
83. Egerman R. Evaluation of the safety of relaxin in severe preeclampsia. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 20 February 2008).
84. Salem H, Ghanemah S, Seleem S, Sayed E, Abdel-Latif A, Chard T. Bromocriptine therapy in pre-eclamptic toxaemia of pregnancy (PET). World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil, 1988. 1988:184.
85. Toppozada M, Barakat T, Shaala S, Ismail AAA. Management of severe pre-eclampsia with prostaglandin A1: a useful therapeutic approach. Journal of Obstetrics and Gynaecology 1989;9:184-8.
86. Toppozada M, Medhat I, Sallam H, Ismail AAA, El-Badawy ES, Rabbo SA. Improving placental blood flow in pre-eclampsia with prostaglandin A1. Acta Obstetricia et Gynecologica Scandinavica 1992;71:22-7.
87. Esmaoglu A, Ulgey A, Akin A, Boyaci A. Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit. Journal of Critical Care 2009;24(4):551-5.
88. Fievet P, El Esper N, Gueroult J, Gueroult J, Fournier A. Comparative study of clonidine and labetalol in severe hypertension induced by pregnancy. 5th International Congress for the International Society for the study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, England. 1986:136.
89. Kwawukume EY, Ghosh TS. Oral nifedipine therapy in the management of severe preeclampsia. International Journal of Gynecology & Obstetrics 1995;49:265-9.
90. Graves SW, Hopoate-Sitake M, Johnston A, Buckalew V, Lam G, Mason L, et al. Deep trial secondary analysis: Digoxin immune fab fragment treatment has additional benefits in endogenous digitalis-like factor positive preeclamptic women. Pregnancy Hypertension 2012;2(3):287-8.
91. Gris JC, Chauleur C, Molinari N, Mares P, Fabbro-Peray P, Quere I, et al. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia: The pilot randomised controlled NOH-PE trial. Thrombosis and Haemostasis 2011;106(6):1053-61.
92. Hladunewich MA, Derby GC, Lafayette RA, Blouch KL, Druzin ML, Myers BD. Effect of L-Arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial. Obstetrics & Gynecology 2006;107(4):886-95.
93. Hopate M, Graves S, Adair CD, Lam G, Johnson D, Saade G, et al. In-vivo reversal of functional sodium pump inhibition with Digibind treatment. Hypertension in Pregnancy 2008;27(4):460.
94. Daftary SN, Desa Souza JM, Kumar A, Mandrekar SS, Lotlikar KD, Sheth UK. A controlled clinical trial of guanethidine in toxemia of pregnancy. Indian Journal of Medical Sciences 1963;17:812-8.
95. Samal S, Gupta U, Agarwal P. Management of eclampsia with magnesium sulphate and nifedipine. Journal of Obstetrics and Gynecology of India 2001;51(3):71-4.
96. Ghahiri A, Salehpour S. The effect of nifedipin on the BP of the patients with severe preeclampsia. International Journal of Gynecology & Obstetrics 1994;46:121.
97. Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstetrics & Gynecology 1991;77:331-7.
98. Thaler I, Amit A, Kamil D, Itskovitz-Eldor J. The effect of isosorbide dinitate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension. American Journal of Hypertension 1999;12:341-7.
99. Paternoster DM, Fantinato S, Manganelli F, Milani M, Nicolini U, Girolami A. Efficacy of AT in pre-eclampsia: a case control prospective trial. Thrombosis and Haemostasis 2004;91(2):283-9.
100. Fletcher H, Roberts G, Mullings A, Forrester T. An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia. Journal of Obstetrics and Gynaecology 1999;19:235-8.
101. Fletcher H, Roberts G, Mullings A, Simeon DT, Forrester TE. An open trial comparing usual care (hydralazine) with injectable isradipine in severe pre-eclampsia [abstract]. West Indian Medical Journal 1996;45(2 Suppl):27.
102. Kanayama N, Belayet HM, Khatun S, Tokunaga N, Sugimura M, Kobayashi T, et al. A new treatment of severe pre-eclampsia by long term epidural anaesthesia. Journal of Human Hypertension 1999;13:167-71.
103. Maki M, Kobayashi T, Terao T, Ikenoue T, Satoh K, Nakabayashi M, et al. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. Bi51.017 Study group. Thrombosis and Haemostasis 2000;84(4):583-90.
104. Seki H, Takeda S, Kinoshita K. Long-term treatment with nicardipine for severe pre-eclampsia. International Journal of Gynecology & Obstetrics 2002;76:135-41.
105. Kobayashi T, Terao T, Ikenoue T, Sameshima H, Nakabayashi M, Kajiwara Y, et al. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study. Seminars in Thrombosis and Hemostasis 2003;29(6):645-52.
106. Johnston A. Efficacy study of digibind for treatment of severe preeclampsia (ongoing trial). ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 21 March 2006).
107. Lam G, Johnson D, Robinson C, Saade G, Lewis D, Porter K, et al. Antepartum administration of a digoxin immune fab (Digibind) improves renal function in patients with severe preeclampsia. Hypertension in Pregnancy 2008;27(4):422.
108. Jegasothy R, Paranthaman S. Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. Journal of Obstetrics and Gynaecology Research 1996;22:21-4.
109. Manzur-Verastegui S, Mandeville PB, Gordillo-Moscoso A, Hernandez-Sierra JF, Rodriguez-Martinez M. Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial. Clinical and Experimental Pharmacology and Physiology 2008;35(5-6):580-5.
110. Sandoval JB, Perez FR. Study of glomerular filtration in toxemia of pregnancy. Modifications with the use of furosemid (lasix) [abstract]. 5th World Congress of Gynecology and Obstetrics; 1967; Sydney, Australia. 1967:891.
111. Martinez-Abundis E, Gonzalez-Ortiz M, Hernandez-Salazar F, Huerta-J-Lucas MT. Sublingual isosorbide dinitrate in the acute control of hypertension in patients with severe preeclampsia. Gynecologic and Obstetric Investigation 2000;50:39-42.
112. Pardo-Morales RV, Romero-Figueroa S, Vazquez-de Anda GF, Briones-Garduno JC, Herrera-Villalobos JE, Gonzalez-Vargas A. New therapeutics alternative in severe preeclampsia. Cirugia y Cirujanos 2004;72(3):203-7.
113. Roes EM, Raijmakers MTM, Zusterzeel PLM, De Boo T, Merkus JMWM, Peters WHM, et al. Oral n-acetylcysteine supplementation does not prolong pregnancy in women with severe preeclampsia: a randomised, placebo-controlled trial [abstract]. Hypertension in Pregnancy 2002;21(Suppl 1):47.
114. Lubbe W. Maternal and fetal responses to b-blockers with and without ISA in hypertensive pregnancy. 5th International Congress for the International Society for the study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, England. 1986:89.
115. Duggan PM, McCowan LME, Stewart AW. Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension. Australian and New Zealand Journal of Obstetrics and Gynaecology 1992;32:335-8.
116. Decano MB, Cabrera LT. The effects of transdermal nitroglycerin (nitrol patch) on the uterine and umbilical artery blood flow in preeclampsia: a randomized double blind placebo controlled study [abstract]. XVI FIGO World Congress of Obstetrics & Gynecology; 2000 Sept 3-8; Washington DC, USA (Book 1). 2000:26.
117. Pogue V, Ticas R, Sandoval X. Removal of agonistic autoantibodies against the angiotensin AT receptor in patients with preeclampsia [abstract]. Journal of the American Society of Nephrology 2006;17:658A.
118. Roes EM, Raijmakers MT, Boo TM, Zusterzeel PL, Merkus HM, Peters WH, et al. Oral n-acetylcysteine administration does not stabilise the process of established severe preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 2006;127(1):61-7.
119. Samangaya RA, Mires G, Shennan A, Skillern L, Howe D, McLeod A, et al. A randomised, double-blinded, placebo-controlled trial of the phosphodiesterase type 5 inhibitor sildenafil in the treatment of preeclampsia. Hypertension in Pregnancy 2009;28:369-82.
120. Samangaya RA, Wareing M, Skillern L, Baker PN. Phosphodiesterase inhibitor effect on small artery function in preeclampsia. Hypertension in Pregnancy 2011;30(2):144-52.
121. Schackis RC. Hyperuricaemia and preeclampsia: is there a pathogenic link?. Medical Hypotheses 2004;63(2):239-44.
122. Walker JJ, Greer I, Calder AA. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared. Postgraduate Medical Journal 1983;59:168-70.
123. Ratnam SS, Lean TH, Sivasamboo R. A comparison of hypotensive drugs in patients with hypertensive disorders in late pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 1971;11:78-84.
124. Smith D, Warren J, Saade G, Clark S, Belfort M. Oral labetalol given to treated non hypertensive patients with preeclampsia is no more likely to cause hypotension than magnesium sulfate [abstract]. American Journal of Obstetrics and Gynecology 2005;193(6 Suppl):S78.
125. Garden A, Davey DA, Dommisse J. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. Clinical and Experimental Hypertension 1982;B1:371-83.
126. Sankar D, Moodley J. Low-dose diazoxide in the emergency management of severe hypertension in pregnancy. South African Medical Journal 1984;65:279-80.
127. Bhorat IE, Datshana P, Naidoo P, Rout CC, Moodley J. Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine. American Journal of Obstetrics and Gynecology 1993;168:1292-6.
128. Bhorat IE, Naidoo DP, Rout CC, Moodley J. Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine. Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 march 15-18; Sydney, Australia. 1994:162.
129. van Schie D, de Jeu R, Steyn D, Odendaal H, van GH. The optimal dosage of ketanserin for pateints with severe hypertension in pregnancy. European Journal Obstetrics & Gynecology and Reproductive Biology 2002;102:161-6.
130. Cararach V, Torres Pons PJ, Roca M, Codina C, Cobo E, Gonzalez-Merlo J. Treatment of severe hypertension in pregnancy. Double blind controlled trial a treatment pattern (TP) with hydralazine + methyldopa a single TP with labetolol. Proceedings of 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Canada. 1988:101.
131. Steyn DW, Hall DR, Odendaal H. The optimal dosage of nifedipine in patients with early onset severe pre-eclampsia - a randomised controlled trial. 22nd Conference on Priorities in Perinatal Care in South Africa; 2003 March 11-14; Free State, South Africa. 2003.
132. Hjertberg R, Faxelius G, Belfrage P. Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants. Acta Obstetricia et Gynecologica Scandinavica 1993;72:611-5.
133. Hjertberg R, Faxelius G, Lagercrantz H. Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment. Journal of Perinatal Medicine 1993;21:69-75.
134. Hjertberg R, Faxelius G, Lagercrantz H. Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment. Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland. 1994:18.
135. Unemori E, Sibai B, Teichmana SL. Scientific rationale and design of a phase I safety study of relaxin in women with severe preeclampsia. Annals of the New York Academy of Sciences 2009;1160:381-4.
136. Scardo JA, Vermillion ST, Newman RB, Chauhan SP, Brost B. Randomized double blinded hemodynamic study of oral nifedipine and IV labetolol in hypertensive urgencies of pregnancy. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S18.
137. Scardo JA, Vermillion ST, Newman RB, Chauhan SP, Hogg BB. A randomized double blind hemodynamic evaluation of nifedipine and labetolol in preeclamptic hypertensive emergencies. American Journal of Obstetrics and Gynecology 1999;181:862-6.
138. Vermillion S, Scardo J, Newman R, Chauhan S. A prospective randomized double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S14.
139. Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies of pregnancy. American Journal of Obstetrics and Gynecology 1999;181:858-61.
140. Reyna-Villasmil E, Prieto-Franchi M, Guerra-Velazquez M, Torres-Montilla M. Effect of transdermal nitroglycerin on umbilical artery blood flow in preeclampsia [abstract]. Journal of Perinatal Medicine 2001;29 Suppl 1(Pt 2):486.
141. Waheed F, Chohan A. Comparison of intravenous hydralazine-bolus dose versus continuous infusion drip in eclampsia. Annals of King Edward Medical College 2005;11(4):521-3.
142. Chandran JR, Devi U, Devi S, Khadeeja M, Vinayachandran S, Jacob KJ, et al. LAMPET Trial (labetalol vs magnesium sulfate in prevention of eclampsia trial). 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India. 2011:55.
143. Warren J, Lacoursiere Y, Varner M, Silver R, Anthony J, Belfort M. First interim report on the labetalol versus magnesium sulfate for the prevention of eclampsia trial (LAMPET) [abstract]. Hypertension in Pregnancy 2004;23(Suppl 1):9.
144. Mesquita MRDS, Atallah AN, Rocha NDSC, Camano L, Bertini AM. The use of hydralazine and nifedipine in hypertensive emergencies in pregnancy [Emprego da hidralazina e da nifedipina nas emergencias hipertensivas na gestacao]. Revista Brasileira de Ginecologia e Obstetricia 1995;17(2):103-11.
145. Diemunsch PA. Treatment of severe hypertension during pre-eclampsia. A preliminary equivalence study between urapidil and nicardipine. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 20 February 2008).
146. Abalos E, Duley L, Steyn DW, Henderson-Smart David J. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD002252.pub2]
147. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG: an international journal of obstetrics and gynaecology 2011;118(Suppl. 1):1-203.
148. Churchill D, Duley L. Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003106]
149. Clarke M, Oxman AD, editors. Cochrane Reviewers' Handbook 4.1.5 [updated April 2002]. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated quarterly.
150. Redman CWG. Hypertension. In: de Swiet M editor(s). Medical Disorders in Obstetric Practice. 4th Edition. Blackwell Scientific Publications, 2002:159.
151. Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of pre-eclampsia. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD001805]
152. Duley L, Henderson-Smart DJ, Walker GJA. Interventions for treating pre-eclampsia and its consequences: generic protocol. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD007756]
153. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD000025.pub2]
154. Duley L, Gülmezoglu AM, Chou D. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD002960.pub2]
155. Hennessy A, Thornton CE, Makris A, Ogle RF, Henderson-Smart DJ, Gillin AG, et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. Australian and New Zealand Journal of Obstetrics and Gynaecology 2007;47(4):279-85. [PUBMED: 17627681]
156. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
157. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. Journal of the American Society of Hypertension 2008;2(6):484-94.
158. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP. Guidelines for the management of hypertensive disorders of pregnancy. Australia and New Zealand Journal of Obstetrics and Gynaecology 2009;49(3):242-6.
159. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003;327:955.
160. Magee L, Helewa, ME, Moutquin, JM, von Dadelszen, P Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology Canada 2008;30(Supp 1):S1-S48.
161. National Institute of Clinical Excellence. NICE clinical guideline No. 107. Hypertension in Prenancy. Management of Hypertensive Disorders in Pregnancy. http://www.nice.org.uk/nicemedia/live/13098/50418/50418.pdf 2010.
162. The Cochrane Collaboration. Review Manager (RevMan). 4.1 for Windows. Oxford, England: The Cochrane Collaboration, 2000.
163. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
164. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009;30(Suppl 1):32-7.
165. Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clinical and Experimental Hypertension 2008;30(8):744-66.
166. Tuffnell D, Shennan AH, Waugh JJS, Walker JJ. The management of severe pre-eclampsia/eclampsia. RCOG guideline number 10(A). Royal College of Obstetricians and Gynaecologists, 2006.
167. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 1988;158:80-3.
168. World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia. http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf (accessed 2013) 2011.
169. Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD008148.pub2]
170. Duley L. IV labetalol vs iv diazoxide in severe pre-eclampsia. In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995.
171. Duley L. Labetalol vs hydralazine in severe pregnancy-induced hypertension. In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995.
172. Duley L. Nifedipine vs hydralazine in severe pregnancy-induced hypertension. In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995.
173. Duley L. Prostacyclin vs dihydralazine in severe hypertension. In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995.
174. Duley L, Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 1999, Issue 2. [DOI: 10.1002/14651858.CD001449]
175. Duley L, Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD001449]
176. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001449.pub2]